Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix

Journal of Controlled Release

Volumn 89, Issue 3, 2003, Pages 409-417

  Gilbert, Jake A ^a   Simpson, Amanda E ^a,b   Rudnick, David E ^a   Geroski, Dayle H ^a   Aaberg Jr , Thomas M ^a   Edelhauser, Henry F ^a  

^a EMORY EYE CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cisplatin; Collagen matrix; Drug delivery; Retinoblastoma; Vitreous

Indexed keywords

COLLAGEN; CONTROLLED DRUG DELIVERY; DISEASES; DRUG PRODUCTS; MECHANICAL PERMEABILITY; TISSUE;

DRUG INJECTION;

PLATINUM COMPOUNDS;

BALANCED SALT SOLUTION; CISPLATIN; COLLAGEN GEL; DRUG VEHICLE;

ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHOROID; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG PENETRATION; ENUCLEATION; EYE; FREEZE DRYING; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINA; SCLERA; TISSUE DISTRIBUTION; TISSUE PRESERVATION;

EID: 0037726627     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00151-2     Document Type: Article

References (35)

1. Friedman D.L., Himelstein B., Shields C.L., Shields J.A., Needle M., Miller D., Bunin G.R., Meadows A.T. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J. Clin. Oncol. 18:(1):2000;12-17.
2. Gallie B.L., Budning A., DeBoer G., Thiessen J.J., Koren G., Verjee Z., Ling V., Chan H.S.L. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch. Ophthalmol. 114:1996;1321-1328.
3. Shields C.L., De Potter P., Himelstein B.P., Shields J.A., Meadows A.T., Maris J.M. Chemoreduction in the initial management of retinoblastoma. Arch. Ophthalmol. 114:1996;1330-1338.
4. Murphree A.L., Villablanca J.G., Deegan III W.F., Sato J.K., Malogolowkin M., Fisher A., Parker R., Reed E., Gomer C.J. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch. Ophthalmol. 114:1996;1348-1356.
5. Shields C.L., Shields J.A. Recent developments in the management of retinoblastoma. J. Pediatr. Ophthalmol. Strabismus. 36:(1):1999;8-18.
6. Rudnick D.E., Noonan J.S., Geroski D.H., Prausnitz M.R., Edelhauser H.F. The effect of intraocular pressure on human and rabbit scleral permeability. Invest. Ophthalmol. Vis. Sci. 40:(12):1999;3054-3058.
7. Olsen T.W., Edelhauser H.F., Lim J.I., Geroski D.H. Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest. Ophthalmol. Vis. Sci. 36:(9):1995;1893-1903.
8. Ambati J., Canakis C.S., Miller J.W., Gragoudas E.S., Edwards A., Weissgold D.J., Kim I., Delori F.C., Adamis A.P. Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci. 41:(5):2000;1181-1185.
9. Ambati J., Gragoudas E.S., Miller J.W., You T.T., Miyamoto K., Delori F.C., Adamis A.P. Transscleral delivery of bioactive protein to the choroid and retina. Invest. Ophthalmol. Vis. Sci. 41:(5):2000;1186-1191.
10. Prausnitz M.R., Edwards A., Noonan J.S., Rudnick D.E., Edelhauser H.F., Geroski D.H. Measurement and prediction of transient transport across sclera for drug delivery to the eye. Ind. Eng. Chem. Res. 37:(8):1998;2903-2907.
11. Prausnitz M.R., Noonan J.S. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J. Pharm. Sci. 87:(12):1998;1479-1488.
12. Ahmed I., Gokhale R.D., Shah M.V., Patton T.F. Physiochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J. Pharm. Sci. 76:(8):1987;583-586.
13. Unlu N., Robinson J.R. Scleral permeability to hydrocortisone and mannitol in the albino rabbit eye. J. Ocul. Pharmacol. Ther. 14:(3):1998;273-281.
14. Kim J., Lindsey J.D., Wang N., Weinreb R.N. Increased human scleral permeability with prostaglandin exposure. Invest. Ophthalmol. Vis. Sci. 42:(7):2001;1514-1521.
15. Hamalainen K.M., Kananen K., Auriola S., Kontturi K., Urtti A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest. Ophthalmol. Vis. Sci. 38:(3):1997;627-634.
16. Murray T.G., Cicciarelli N., O'Brien J.M., Hernandez E., Mueller R.L., Smith B.J., Feuer W. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma. Arch. Ophthalmol. 115:1997;1286-1290.
17. Hayden B.H., Murray T.G., Scott I.U., Cicciarelli N., Hernandez E., Feuer W., Fulton L., O'Brien J.M. Subconjunctival carboplatin in retinoblastoma. Arch. Ophthalmol. 118:2000;1549-1554.
18. Mendelsohn M.E., Abramson D.H., Madden T., Tong W., Tran H.T., Dunkel I.J. Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Arch. Ophthalmol. 116:(9):1998;1209-1212.
19. Abramson D.H., Frank C.M., Dunkel I.J. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology. 106:(10):1999;1947-1950.
20. Simpson A.E., Gilbert J.A., Rudnick D.E., Geroski D.H., Aaberg T.M. Jr., Edelhauser H.F. Transscleral diffusion of carboplatin: an in vitro and in vivo study. Arch. Ophthalmol. 120:2002;1069-1074.
21. Lillehei K.O., Kong Q., Withrow S.J., Kleinschmidt-DeMasters B. Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat. Neurosurgery. 39:(6):1996;1191-1199.
22. Shikani A.H., Eisele D.W., Domb A.J. Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 120:1994;1242-1247.
23. Shikani A.H., Domb A.J. Polymer chemotherapy for head and neck cancer. Laryngoscope. 110:(6):2000;907-917.
24. Yapp D.T.T., K Lloyd D., Zhu J., Lehnert S.M. Tumor treatment by sustained intratumoral release of cisplatin: effects of drug alone and combined with radiation. Int. J. Radiat. Oncol. Biol. Phys. 39:(2):1997;497-504.
25. Mok T.S.K., Kanekal S., Lin X.R., Leung T.W.T., Chan A.T.C. S., Yeo W., Yu S., Chak K., Leavitt R., Johnson P. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma. Cancer. 91:(12):2001;2369-2377.
26. Begg A.C., Bartelink H., Stewart F.A., Brown D.M., Luck E.E. Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system. J. Natl. Cancer Inst. Monogr. 6:1988;133-136.
27. Di Felice V., Lauricella M., Giuliano M., Emanuele S., Vento R., Tesoriere G. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. Int. J. Oncol. 13:1998;225-232.
28. Madden T., Sunderland M., Santana V.M., Rodman J.H. The pharmacokinetics of high-dose carboplatin in pediatric patients with cancer. Clin. Pharmacol. Ther. 51:(6):1992;701-707.
29. Forster S., Mead A., Sears M. An interophthalmic communicating artery as explanation for consensual irritative response of the rabbit eye. Invest. Ophthalmol. Vis. Sci. 18:(2):1979;161-165.
30. Abramson D.H., Frank C.M., Chantada G.L., de Totah A.B., de Pifano I., Ramirez G., Gomez R., Fandino A., Tran H.T., Madden T., Dunkel I.J. Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma. Ophthal. Genet. 20:(1):1999;31-36.
31. DeConti R.C., Toftness B.R., Lange R.C., Creasey W.A. Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Res. 33:1973;1310-1315.
32. Thompson S.W., Davis L.E., Kornfeld M., Hilgers R.D., Standefer J.C. Cisplatin neuropathy. Clinical, electrophysiological, morphologic, and toxicologic studies. Cancer. 54:1984;1269-1275.
33. Helson L., Okonkwo E., Anton L., Cvitkovic E. cis-Platinum ototoxicity. Clin. Toxicol. 13:(4):1978;469-478.
34. Hennings H., Shores R.A., Poirier M.C., Reed E., Tarone R.E., Yuspa S.H. Enhanced malignant conversion of benign mouse skin tumors by cisplatin. J. Natl. Cancer. Inst. 82:(10):1990;836-840.
35. Peyman G.A., Greenberg D., Fishman G.A., Fiscella R., Thomas A. Evaluation of toxicity of intravitreal antineoplastic drugs. Ophthal. Surg. 15:(5):1984;411-413.